Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChesnara Regulatory News (CSN)

Share Price Information for Chesnara (CSN)

Share Price is delayed by 15 minutes
Get Live Data
333.00    -2.00 (-0.60%)
Bid:
333.50
Ask:
334.50
Spread: 1.00 (0.30%)
Market Cap: £768.24m
CSN Live PriceLast checked at - London Stock Exchange

Intraday Chesnara Share Chart

Director/PDMR Shareholding

28 Apr 2016 14:32

RNS Number : 7045W
Chesnara PLC
28 April 2016
 

 

Annex DTR3

 

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons

 

 

All relevant boxes should be completed in block capital letters.

 

1.

Name of the issuer: CHESNARA PLC

 

2.

State whether the notification relates to (i) a

transaction notified in accordance with DTR 3.1.2 R,

 

3.

Name of person discharging managerial

responsibilities/director

 

JOHN DEANE

4.

State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person. N/A

 

5.

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a nonbeneficial

interest 1

 

N/A

6.

Description of shares (including class), debentures or derivatives or financial instruments relating to shares

 

 

N/A

7.

Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

 

N/A

8.

State the nature of the transaction

 

 

N/A

9.

Number of shares, debentures or financial

instruments relating to shares acquired

 

N/A

10.

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

 

N/A

 

11.

Number of shares, debentures or financial

instruments relating to shares disposed

 

N/A

12.

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

 

N/A

 

13.

Price per share or value of transaction

 

N/A

 

14.

Date and place of transaction

 

N/A

15.

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

 

16.

Date issuer informed of transaction

N/A

 

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes:

 

17.

Date of grant

 

28 APRIL 2016

 

18.

Period during which or date on which exercisable

 

GRANT 1

THE OPTION WILL BECOME EXERCISABLE ON 28 APRIL 2019 AND REMAIN EXERCISABLE UP TO AND INCLUDING 27 APRIL 2026 IF NOT EXERCISED BEFORE THAT DATE.

 

GRANT 2

SUBJECT TO THE ACHIEVEMENT OF THE PERFORMANCE TARGET, THE OPTION WILL BECOME EXERCISABLE ON 28 APRIL 2019 AND REMAIN EXERCISABLE UP TO AND INCLUDING 27 APRIL 2026 IF NOT EXERCISED BEFORE THAT DATE.

 

19.

Total amount paid (if any) for grant of the option - NIL

20.

Description of shares or debentures involved (class and number)

 

GRANT 1

26,575 ORDINARY SHARES OF 5P EACH

 

 

GRANT 2

133,017 ORDINARY SHARES OF 5P EACH

 

21.

Exercise price (if fixed at time of grant) or

indication that price is to be fixed at the time of exercise - NIL

 

22.

Total number of shares or debentures over which options held following notification

 

250,529 ORDINARY SHARES OF 5P EACH

 

23.

Any additional information

 

GRANT 1

GRANTED UNDER THE CHESNARA 2014 SHORT-TERM INCENTIVE SCHEME. THE OPTION IS NOT SUBJECT TO A PERFORMANCE TARGET.

 

GRANT 2

GRANTED UNDER THE CHESNARA 2014 LONG-TERM INCENTIVE SCHEME. THE OPTION IS SUBJECT TO A PERFORMANCE TARGET WHICH IS BASED ON 50% ON TSR, 50% ON EMBEDDED VALUE OF THE COMPANY OVER A PERIOD OF THREE FINANCIAL YEARS.

 

 

24.

Name of contact and telephone number for queries

 

ZOE KUBIAK +44 (0) 1772 972050

 

 

 

1.

Name of the issuer: CHESNARA PLC

 

 

2.

State whether the notification relates to (i) a

transaction notified in accordance with DTR 3.1.2 R,

 

3.

Name of person discharging managerial

responsibilities/director

 

DAVID RIMMINGTON

4.

State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person. N/A

 

5.

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial

interest 1

 

N/A

6.

Description of shares (including class), debentures or derivatives or financial instruments relating to shares

 

 

N/A

7.

Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

 

N/A

8.

State the nature of the transaction

 

 

N/A

9.

Number of shares, debentures or financial

instruments relating to shares acquired

 

N/A

10.

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

 

N/A

 

11.

Number of shares, debentures or financial

instruments relating to shares disposed

 

N/A

12.

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

 

N/A

 

13.

Price per share or value of transaction

 

N/A

 

14.

Date and place of transaction

 

N/A

15.

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) N/A

 

16.

Date issuer informed of transaction

N/A

 

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes:

 

17.

Date of grant

 

28 APRIL 2016

 

18.

Period during which or date on which exercisable

 

GRANT 1

THE OPTION WILL BECOME EXERCISABLE ON 28 APRIL 2019 AND REMAIN EXERCISABLE UP TO AND INCLUDING 27 APRIL 2026 IF NOT EXERCISED BEFORE THAT DATE.

 

GRANT 2

SUBJECT TO THE ACHIEVEMENT OF THE PERFORMANCE TARGET, THE OPTION WILL BECOME EXERCISABLE ON 28 APRIL 2019 AND REMAIN EXERCISABLE UP TO AND INCLUDING 27 APRIL 2026 IF NOT EXERCISED BEFORE THAT DATE.

 

19.

Total amount paid (if any) for grant of the option - NIL

 

 

20.

Description of shares or debentures involved (class and number)

 

GRANT 1

15,434 ORDINARY SHARES OF 5P EACH

 

 

GRANT 2

71,259 ORDINARY SHARES OF 5P EACH

 

21.

Exercise price (if fixed at time of grant) or

indication that price is to be fixed at the time of exercise - NIL

 

22.

Total number of shares or debentures over which options held following notification

 

196,604 ORDINARY SHARES OF 5P EACH

 

23.

Any additional information

 

GRANT 1

GRANTED UNDER THE CHESNARA 2014 SHORT-TERM INCENTIVE SCHEME. THE OPTION IS NOT SUBJECT TO A PERFORMANCE TARGET.

 

GRANT 2

GRANTED UNDER THE CHESNARA 2014 LONG-TERM INCENTIVE SCHEME. THE OPTION IS SUBJECT TO A PERFORMANCE TARGET WHICH IS BASED ON 50% ON TSR, 50% ON EMBEDDED VALUE OF THE COMPANY OVER A PERIOD OF THREE FINANCIAL YEARS.

 

24.

Name of contact and telephone number for queries: ZOE KUBIAK +44 (0) 1772 972050

 

 

 

1.

Name of the issuer: CHESNARA PLC

 

2.

State whether the notification relates to (i) a

transaction notified in accordance with DTR 3.1.2 R,

 

3.

Name of person discharging managerial

responsibilities/director

 

FRANK HUGHES

4.

State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person. N/A

 

5.

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial

interest 1

 

N/A

6.

Description of shares (including class), debentures or derivatives or financial instruments relating to shares

 

 

N/A

7.

Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

 

N/A

8.

State the nature of the transaction

 

 

N/A

9.

Number of shares, debentures or financial

instruments relating to shares acquired

 

N/A

10.

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

 

N/A

 

11.

Number of shares, debentures or financial

instruments relating to shares disposed

 

N/A

12.

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

 

N/A

 

13.

Price per share or value of transaction

 

N/A

 

14.

Date and place of transaction

 

N/A

15.

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

 

16.

Date issuer informed of transaction

 

 

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes:

 

17.

Date of grant

 

28 APRIL 2016

 

18.

Period during which or date on which exercisable

 

GRANT 1

THE OPTION WILL BECOME EXERCISABLE ON 28 APRIL 2019 AND REMAIN EXERCISABLE UP TO AND INCLUDING 27 APRIL 2026 IF NOT EXERCISED BEFORE THAT DATE.

 

GRANT 2

SUBJECT TO THE ACHIEVEMENT OF THE PERFORMANCE TARGET, THE OPTION WILL BECOME EXERCISABLE ON 28 APRIL 2019 AND REMAIN EXERCISABLE UP TO AND INCLUDING 27 APRIL 2026 IF NOT EXERCISED BEFORE THAT DATE.

 

19.

Total amount paid (if any) for grant of the option - NIL

20.

Description of shares or debentures involved (class and number)

 

GRANT 1

14,027 ORDINARY SHARES OF 5P EACH

 

 

GRANT 2

50,364 ORDINARY SHARES OF 5P EACH

 

21.

Exercise price (if fixed at time of grant) or

indication that price is to be fixed at the time of exercise - NIL

 

22.

Total number of shares or debentures over which options held following notification

 

182,768 ORDINARY SHARES OF 5P EACH

 

23.

Any additional information

 

GRANT 1

GRANTED UNDER THE CHESNARA 2014 SHORT-TERM INCENTIVE SCHEME. THE OPTION IS NOT SUBJECT TO A PERFORMANCE TARGET.

 

GRANT 2

GRANTED UNDER THE CHESNARA 2014 LONG-TERM INCENTIVE SCHEME. THE OPTION IS SUBJECT TO A PERFORMANCE TARGET WHICH IS BASED ON 50% ON TSR, 50% ON EMBEDDED VALUE OF THE COMPANY OVER A PERIOD OF THREE FINANCIAL YEARS.

 

24.

Name of contact and telephone number for queries

 

ZOE KUBIAK +44 (0) 1772 972050

 

 

 

 

Name of authorised official of issuer responsible for making notification

Zoe Kubiak

 

Date of notification 28 April 2016

 

 

 

Notes: This form is intended for use by an issuer to make a RIS notification required by DR 3.3.

 

(1)

An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

(2)

An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.

(3)

An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.

(4)

An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHPGUUWCUPQGWR
Date   Source Headline
11th Nov 20227:00 amRNSDirector/PDMR Shareholding
1st Nov 202212:15 pmRNSDirector/PDMR Shareholding
31st Oct 20227:00 amRNSTotal Voting Rights
27th Oct 20222:45 pmRNSDirector/PDMR Shareholding
24th Oct 20227:00 amRNSBlock listing Interim Review
19th Oct 20227:00 amRNSDirector/PDMR Shareholding
3rd Oct 20227:00 amRNSAppointment of Group GC & Company Secretary
29th Sep 20227:00 amRNSBlock Listing Application
12th Sep 20227:15 amEQSHardman & Co Research on Chesnara Plc (CSN): Robust cash generation in challenging markets
8th Sep 202212:05 pmEQSHardman Talks Video: Interview Chesnara management discuss 2022 half-year results
2nd Sep 20227:00 amRNSHolding(s) in Company
31st Aug 20227:00 amRNSHalf-year Report
23rd Aug 20227:00 amRNSHolding(s) in Company
17th Aug 20227:00 amRNSNotice of Interim Results
15th Aug 20222:45 pmEQSHardman & Co: Q&A on Chesnara Plc (CSN) Conservatrix acquisition boosts AuA and cash flow with capacity for more
8th Aug 20227:00 amRNSHolding(s) in Company
5th Aug 20227:00 amRNSHolding(s) in Company
2nd Aug 20227:00 amRNSChesnara Enhances M&A and Commercial Capabilities
29th Jul 20227:15 amEQSHardman & Co Research: Chesnara plc (CSN): Another fine acquisition
22nd Jul 20227:00 amRNSAcquisition
16th Jun 20229:15 amEQSHardman & Co Research: Q&A on Chesnara Plc (CSN): Good performance analysed
31st May 20227:00 amRNSTotal Voting Rights
24th May 20227:00 amEQSHardman & Co Research : Chesnara plc (CSN): Market benefits overwhelm operational challenges
17th May 20221:51 pmRNSResult of AGM
29th Apr 20227:00 amRNSDirector/PDMR Shareholding
28th Apr 20227:00 amRNSAcquisition Completions
22nd Apr 20227:00 amRNSBlock listing Interim Review
21st Apr 20227:00 amRNSNotice of AGM
8th Apr 20227:00 amRNSAcquisition Update
5th Apr 20222:30 pmRNSDirector/PDMR Shareholding
31st Mar 20227:00 amRNSFinal Results
17th Mar 20227:00 amRNSNotice of Results
15th Mar 20227:00 amRNSTotal Voting Rights
14th Feb 20227:00 amRNSDirectorate Change
2nd Feb 20223:07 pmRNS£200m Inaugural Tier 2 Subordinated Notes Issuance
26th Jan 20227:00 amRNSHolding(s) in Company
17th Jan 20227:00 amRNSDirectorate Change
17th Dec 20217:00 amRNSSenior Leadership Appointment
9th Dec 20217:00 amRNSHolding(s) in Company
2nd Dec 20211:50 pmEQSHardman & Co Research : Chesnara (CSN) Initiation of Coverage: Could be the least worrying dividend you'll get
26th Nov 20211:00 pmRNSDirector/PDMR Shareholding
25th Nov 20217:00 amRNSAcquisition
22nd Oct 20217:00 amRNSBlock listing Interim Review
19th Oct 20217:00 amRNSDirectorate Change
13th Sep 20217:00 amRNSProposed Acquisition
7th Sep 20217:00 amRNSHolding(s) in Company
26th Aug 20217:00 amRNSHalf-year Report
12th Aug 20217:00 amRNSNotice of Results
2nd Aug 20217:00 amRNSDirectorate Change
28th May 20214:36 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.